<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0240">
 <label>48</label>
 <element-citation publication-type="journal" id="sbref0240">
  <person-group person-group-type="author">
   <name>
    <surname>Crawford</surname>
    <given-names>K.W.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Keung</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Su</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Hughes</surname>
    <given-names>M.D.</given-names>
   </name>
   <name>
    <surname>Greaves</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Kuritzkes</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Gulick</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Flexner</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Team</surname>
    <given-names>A.A.S.</given-names>
   </name>
  </person-group>
  <article-title>Pharmacokinetic/pharmacodynamic modeling of the antiretroviral activity of the CCR5 antagonist Vicriviroc in treatment experienced HIV-infected subjects (ACTG protocol 5211)</article-title>
  <source>J. Acquir. Immune Defic. Syndr.</source>
  <volume>53</volume>
  <year>2010</year>
  <fpage>598</fpage>
  <lpage>605</lpage>
  <pub-id pub-id-type="pmid">20071999</pub-id>
 </element-citation>
</ref>
